Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis
Key facts
- Who runs it
- University of Pittsburgh
- Where
- Baltimore, Indianapolis, and Pittsburgh, United StatesSee the 3 sites
- Trial code
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 4 Jan 2022
- Expected to end
- 30 Jun 2028
- Type of study
- Interventional
- Treatments tested
- Quantitative Sensory Test 1
- Quantitative Sensory Test 2
- Quantitative Sensory Test 3
- Record updated
- 11 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Adult patients ≥ 18 years of age with definite CP undergoing decompressive invasive treatments (endoscopic therapy or surgery) to relieve main pancreatic duct obstruction due to stones and/or stricture for management of pain; Endoscopic therapy: Endoscopic Retrograde Cholangiopancreatography (ERCP) with pancreatic duct stone removal, stent placement, and/or stricture dilation, ± intraductal lithotripsy or Extracorporeal Shock Wave Lithotripsy (ESWL); Surgery: drainage procedures (Frey and Puestow operations)
Who cannot take part
- Patients who have had endoscopic therapy within the past 12 months
- Patients who have undergone prior pancreatic surgery
- Patients who have resective surgical procedure planned (eg. Whipple procedure, Total Pancreatectomy)
- Patients with chronic pain from conditions other than CP
- Patients < 18 years of age
- Patients with peripheral sensory deficits
- Patients with known pregnancy at the time of study screening**; Note: Women who become pregnant during the course of the study can no longer participate in P-QST testing
Where in United States
- Johns Hopkins Medical InstitutionsBaltimore, United StatesContact: Mahya Faghih, MDTaking people
- Indiana University Medical CenterIndianapolis, United StatesContact: Suzette Schmidt, RNTaking people
- University of Pittsburgh Medical CenterPittsburgh, United StatesContact: Anna E Phillips, MD, MSTaking people
About the trial
What the trial wants to find out
Abdominal pain in chronic pancreatitis (CP) affects up to 90% of patients during the course of their disease, and response to currently available therapies is suboptimal and unpredictable. The proposed clinical trial will evaluate the predictive capability of Pancreatic Quantitative Sensory Testing (P-QST) - a novel assessment of neurosensory phenotyping- for improvement in pain in patients with CP who are undergoing medically-indicated invasive treatment with endoscopic therapy or surgery.
The group in the trial
- Pancreatic Quantitative Sensory Testing (P-QST)Treatment being tested
Definite Chronic Pancreatitis patients undergoing decompressive invasive treatments (endoscopic therapy or surgery) to relieve main pancreatic duct obstruction due to stones and/or stricture for management of pain will undergo P-QST prior to clinically-indicated invasive treatment.
Treatment: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Record updated
- 11 September 2026